H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Halozyme (HALO – Research Report) today and set a price target of $65.00. Mitchell Kapoor has given his Buy rating
H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Halozyme (HALO – Research Report) today and set a price target of $65.00. Mitchell Kapoor has given his Buy rating
In a report released yesterday, Mohit Bansal from Wells Fargo assigned a Buy rating to Halozyme (HALO – Research Report), with a price target of $58.00. The company’s shares closed
David Risinger, an analyst from Leerink Partners, maintained the Hold rating on Halozyme (HALO – Research Report). The associated price target was lowered to $56.00. David Risinger’s rating is based
Benchmark Co. analyst Robert Wasserman maintained a Buy rating on Halozyme (HALO – Research Report) today and set a price target of $60.00. The company’s shares closed yesterday at $54.12.
Morgan Stanley analyst Vikram Purohit maintained a Buy rating on Halozyme (HALO – Research Report) today and set a price target of $64.00. Vikram Purohit has given his Buy rating